维普中文期刊产品整合服务
87篇 您的检索式:作者名="Kramer G L"
    题名 作者 年代 出处 被引量
1The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo显示文摘Dasmahapatra G Lembersky D Kramer L 0,,22:1
2Methanol synthesis over Cu/ZnO catalysts prepared by ball milling显示文摘Huang L Kramer G J Wieldraaijer W 1997Catalysis Letters1997,48,:1
3Phosphomannose isomerase:an efficient selectable marker for plant transformation显示文摘Reed J Privallel L Powell M L Meghji M Dawson J Dunder E Suttie J Wenck A Launis K Kramer C Chang Y F Hansen G Wright M 0,,:1
4Electrochemical determination of organophosphorus compounds and analysis of xanthine oxidase and sulfydryl inhibitor 显示文摘Guilbauh G G Kramer D N Cannon P L 1964Anal Chem1964,36,:1
5Electrochemical determination of cholinesterase and thiocholine esters 显示文摘Kramer D N Cannon P L Guilbault G G 1962Anal Chem1962,34,7:1
6The NANOMEFOS non-contact measurement machine for freeform optics 显示文摘Henselmans R Cacace L A Kramer G F Y 2011Precision Engineering2011,35,4:1
7Molecular beacons-spectral genotyping of human allele显示文摘Kostrikis L G Tyagi S Mhlanga M M Ho D D Kramer F R 1998Science1998,279,:1
8Electrochemical Determination of Cholinesterase and Thiocholine Esters显示文摘KRAMER D N CANNON P L GUILBAULT G G 1962Anal Chem1962,34,7:1
9Development of a Cryptosporidiurn oocyst assay using an automa- ted fiber optic-based biosensor显示文摘Kramer M F Vesey G Look N L 2007J Biol Eng2007,,1:1
10Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus显示文摘Kramer J R Bayless M L Lorenzi G M 2012Clinical Trials2012,9,6:1
11Waterborne Disease; 1993 and 1994 显示文摘Kramer M H Herwaldt B L Craun G F 1996Journal of American Water Work Asso- ciation1996,88,:1
12Case report: the significance of genotyping for the epidemiological tracing of classical swine fever(CSF) 显示文摘Depner K R Strebelow G Staubach Ch Kramer M Teuffert J Botcher L Hoffmann B Beer M Greiser-Wilke I Mettenleiter T 2006Dtsch Tierarztl Wochenschr2006,113,4:1
13Structural basis for the activation of 20S proteasomes by 11S regulators显示文摘Whitby F G Masters E I Kramer L 0,,6808:1
14Administration of growth hormone to pigs alters the relative amount of insulin-like growth factor-I mRNA in liver and skeletal muscle 显示文摘GRANT A L HELFERICHT W G KRAMER S A 1991Journal of Endocrinol- ogy1991,130,3:1
15Outcomes following liver transplantation in intensive care unit patients显示文摘AIM:To determine feasibility of liver transplantation in patients from the intensive care unit (ICU) by estimating graft and patient survival.METHODS:This single center retrospective study included 39 patients who had their first liver transplant directly from the intensive care unit and 927 non-ICU patients who were transplanted from hospital ward or home between January 2005 and December 2010.RESULTS:In comparison to non-ICU patients,ICU patients had a higher model for end-stage liver disease (MELD) at transplant (median:37 vs 20,P < 0.001).Fourteen out of 39 patients (36%) required vasopressor support immediately prior to liver transplantation (LT) with 6 patients (15%) requiring both vasopressin and norepinephrine.Sixteen ICU patients (41%) were ventilator dependent immediately prior to LT with 9 patients undergoing percutaneous tracheostomy prior to transplantation.Twenty-five ICU patients (64%) required dialysis preoperatively.At 1,3 and 5 years after LT,graft survival was 76%,68% and 62% in ICU patients vs 90%,81% and 75% in non-ICU patients.Patient survival at 1,3 and 5 years after LT was 78%,70% and 65% in ICU patients vs 94%,85% and 79% in non-ICU patients.When formally comparing graft survival and patient survival between ICU and nonICU patients using Cox proportional hazards regression models,both graft survival [relative risk (RR):1.94,95%CI:1.09-3.48,P=0.026] and patient survival (RR:2.32,95%CI:1.26-4.27,P=0.007) were lower in ICU patients vs non-ICU patients in single variable analysis.These findings were consistent in multivariable analysis.Although not statistically significant,graft survival was worse in both patients with cryptogenic cirrhosis (RR:3.29,P=0.056) and patients who received donor after cardiac death (DCD) grafts (RR:3.38,P=0.060).These findings reached statistical significance when considering patient survival,which was worse for patients with cryptogenic cirrhosis (RR:3.97,P=0.031) and patients who were transplanted with DCD livers (RR:4.19,P=0.033).Graft survival and patient survival were not significantly worse for patients on mechanical ventilation (RR:0.91,P=0.88 in graft loss;RR:0.69,P=0.56 in death) or patients on vasopressors (RR:1.06,P=0.93 in graft loss;RR:1.24,P=0.74 in death) immediately prior to LT.Trends toward lower graft survival and patient survival were observed for patients on dialysis immediately before LT,however these findings did not approach statistical significance (RR:1.70,P=0.43 in graft loss;RR:1.46,P=0.58 in death).CONCLUSION:Although ICU patients when compared to non-ICU patients have lower survivals,outcomes are still acceptable.Pre-transplant ventilation,hemodialysis,and vasopressors were not associated with adverse outcomes.Lena Sibulesky Michael G Heckman C Burcin Taner Juan M Canabal Nancy N Diehl Dana K Perry Darren L Willingham Surakit Pungpapong Barry G Rosser David J Kramer Justin H Nguyen 2013World Journal of Hepatology2013,5,1:1
16Structural basis for the activation of 20S proteasomes by 11S regulators 显示文摘Whitby F G Masters E I Kramer L 2000Nature2000,408,6808:1
17Identification of the mechanism for the inhibition of Na,kadenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2显示文摘Xia P Kramer R M King G L 1995Clin Invest1995,96,:1
18Molecular epide- miology of eastern equine encephalitis virus, New York 显示文摘YOUNG D S 'KRAMER L D MAFFEI J G 2008Emerg Infect Dis2008,14,3:1
19Amplitude equations for description of chemical reaction-diffusion systems 显示文摘lpsen M Kramer L Srensen P G 2000Physics Reports2000,337,1:1
20Early endothelial progenitor cells as a source of myeloid cells to improve the pre-vaseularisation of bone constructs 显示文摘Shi Y Kramer G Schroder L 2014Eur Cell Mater2014,27,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费